Segall Bryant & Hamill’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-477	Closed	-$200K	–	716
2022 Q4	$200K	Sell	477 -15	-3%	-$6.05K	﹤0.01%	694
2022 Q3	$204K	Sell	492 -22	-4%	-$11K	﹤0.01%	700
2022 Q2	$253K	Sell	514 -12	-2%	-$6.25K	﹤0.01%	684
2022 Q1	$295K	Sell	526 -7,109	-93%	-$4.29M	﹤0.01%	680
2021 Q4	$5.77M	Sell	7,635 -2,423	-24%	-$1.81M	0.05%	308
2021 Q3	$7.5M	Sell	10,058 -2,920	-22%	-$2.19M	0.07%	253
2021 Q2	$8.36M	Sell	12,978 -134	-1%	-$81.6K	0.08%	239
2021 Q1	$7.49M	Buy	13,112 +1,645	+14%	+$974K	0.07%	260
2020 Q4	$6.68M	Sell	11,467 -11,388	-50%	-$6.49M	0.07%	244
2020 Q3	$11.8M	Buy	22,855 +2,606	+13%	+$1.32M	0.16%	142
2020 Q2	$9.14M	Sell	20,249 -4,369	-18%	-$1.93M	0.15%	143
2020 Q1	$8.63M	Buy	24,618 +744	+3%	+$274K	0.18%	118
2019 Q4	$8.83M	Sell	23,874 -1,618	-6%	-$570K	0.14%	153
2019 Q3	$8.48M	Buy	25,492 +91	+0.4%	+$29.7K	0.13%	192
2019 Q2	$7.94M	Buy	25,401 +547	+2%	+$164K	0.12%	208
2019 Q1	$7.6M	Sell	24,854 -358	-1%	-$96.6K	0.12%	213
2018 Q4	$5.86M	Buy	25,212 +573	+2%	+$154K	0.1%	241
2018 Q3	$7.71M	Sell	24,639 -1,132	-4%	-$351K	0.11%	231
2018 Q2	$7.44M	Sell	25,771 -1,366	-5%	-$377K	0.11%	232
2018 Q1	$6.79M	Sell	27,137 -1,787	-6%	-$455K	0.16%	150
2017 Q4	$6.9M	Sell	28,924 -6,229	-18%	-$1.51M	0.15%	155
2017 Q3	$7.81M	Buy	35,153 +3,790	+12%	+$853K	0.18%	132
2017 Q2	$7.1M	Sell	31,363 -285	-0.9%	-$62.1K	0.17%	136
2017 Q1	$6.31M	Buy	31,648 +3,000	+10%	+$578K	0.15%	148
2016 Q4	$5.22M	Buy	28,648 +2,542	+10%	+$433K	0.13%	166
2016 Q3	$4.28M	Buy	+26,106	New	+$3.96M	0.11%	195